Viking Therapeutics
bd_bc4493145be160c4 · schema v1 · pii pii-v1
Full breach record for Viking Therapeutics →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group ALPHV / BlackCat on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Source provenance
- Source URL
- https://www.ransomware.live/id/VmlraW5nIFRoZXJhcGV1dGljc0BhbHBodg==
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Dec 19, 2023
- Raw hash
- 1f035a6b6d43ba888add9f4a6fd0f08387e372ce92b1626151bf0f7564a21357
Reporting entity
- Name
- alphv
Victim entity
- Name
- Viking Therapeuticsnorm: viking therapeutics
- Domain
- vikingtherapeutics.com
- Industry
- Healthcarellm
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· alphv
- Threat actor
- ALPHVExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.